Clinical trials · Kansas City, MO
Chronic Inflammatory Demyelinating Polyneuropathy clinical trials in Kansas City
We’re tracking 5 recruiting chronic inflammatory demyelinating polyneuropathy studies with a site in or near Kansas City — including Phase 2, Phase 2/Phase 3 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Kansas City
- NCT05327114RecruitingPhase 2/Phase 3
Nipocalimab for adults with chronic inflammatory CIDP nerve disease
This trial tests nipocalimab (an antibody medicine) to improve symptoms and control activity in chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disease that causes weakness and numbness. It may help reduce disease activity and disability, while checking safety.
Kansas City, MissouriAges 18 years+ - NCT07032662RecruitingPhase 2
Testing Imeroprubart for adults with CIDP
This trial tests a new drug called Imeroprubart for people with CIDP who are already on a stable treatment like steroids or immunoglobulin. The goal is to see if the drug can help control symptoms better.
Kansas City, KansasAges 18 years+ - NCT06859099Enrolling by invitationPhase 3
Long-term safety study of Riliprubart for CIDP
This study checks the long-term safety and how well riliprubart works for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It is for those who have already taken riliprubart in a previous study.
Kansas City, KansasAges 18 years+ - NCT06858579RecruitingPhase 3
Testing DNTH103 for chronic inflammatory demyelinating polyneuropathy (CIDP)
This trial tests a new drug called DNTH103 for adults with CIDP, a condition that affects nerves and causes weakness. It aims to see if the drug can help people who are currently on treatment, have tried treatment before, or are new to treatment.
Kansas City, KansasAges 18–75 - NCT06290141RecruitingPhase 3
Testing riliprubart vs. standard IVIg for CIDP
This trial tests whether a new medication called riliprubart works as well as the usual IVIg treatment for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It may offer another option for managing your condition.
Kansas City, KansasAges 18 years+
Hear when a new Chronic Inflammatory Demyelinating Polyneuropathy trial opens near Kansas City, MO
We’ll email you when one opens near Kansas City, MO — at most once a week, no account needed, unsubscribe anytime.
Chronic Inflammatory Demyelinating Polyneuropathy trials in other cities
Where these studies are running near Kansas City
Institutions with a site for the recruiting chronic inflammatory demyelinating polyneuropathy studies listed above.
- University of Kansas Medical Center · 3 studies
- Clinical Study Site
- Kansas City Veterans Affairs Medical Center
- Site Number - 1602
What taking part in a chronic inflammatory demyelinating polyneuropathy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting chronic inflammatory demyelinating polyneuropathy studies in Missouri.
Common questions
- Are there chronic inflammatory demyelinating polyneuropathy clinical trials near Kansas City?
- Yes. We're currently tracking 5 recruiting chronic inflammatory demyelinating polyneuropathy studies with a site near Kansas City, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a chronic inflammatory demyelinating polyneuropathy study near Kansas City?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Kansas City to take part?
- Not necessarily. These studies have a site near Kansas City, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a chronic inflammatory demyelinating polyneuropathy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New chronic inflammatory demyelinating polyneuropathy studies open near Kansas City regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.